Matthew Winton

Insider Reports History

Entity
Individual
Location
C/O Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston, MA
Signature
/s/ Sanjay Subramanian, as attorney-in-fact for Matthew Winton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Winton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inozyme Pharma, Inc. COO Common Stock 4.9K $21.8K $4.45 Sep 30, 2024 Direct
Inozyme Pharma, Inc. COO Stock Option (right to buy) 175K Mar 13, 2024 Direct

Insider Reports Filed by Matthew Winton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INZY Inozyme Pharma, Inc. Sep 30, 2024 1 $7.61K 4 Oct 3, 2024 COO
INZY Inozyme Pharma, Inc. Mar 28, 2024 1 $10.6K 4 Apr 3, 2024 COO
INZY Inozyme Pharma, Inc. Mar 13, 2024 1 $0 4 Mar 15, 2024 COO
INZY Inozyme Pharma, Inc. Apr 3, 2023 1 $0 4 Apr 4, 2023 COO
INZY Inozyme Pharma, Inc. Apr 3, 2023 0 $0 3 Apr 4, 2023 COO